ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 3
Abstract
Malaria is holoendemic in India, claiming thousands of deaths annually. Recent data suggests that the burden of malaria, the most significant parasitic disease in the world, is increasing. India’s expansive geography and diverse climate supports ideal environment for sustaining malarial parasites and their vectors. The National Drug Policy of India recommends artemisinin based combination treatment for the management of malaria. Although the use of Artemisinin has strengthened global efforts to combat malaria, multi-drug resistance has increasingly become a major impediment to malaria control. The complete clearance of parasites is dependent on the partner drug in the combination being effective and also persisting at parasiticidal concentrations until most of the infecting parasites have been killed. Arterolane maleate (150mg) and piperaquine phosphate (750mg) combination is a novel antimalarial combination that is not based on artemisinin. This combination provides rapid clearance of parasitemia and malaria-related symptoms, coupled with prevention of recrudescence. Additionally, a short course treatment of 3 days encourages compliance. Combination of arterolane and piperaquine is a safe and well-tolerated drug combination, making it a welcome addition to the armamentarium against Plasmodium falciparum.
Authors and Affiliations
Suruchi Aditya*| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Ruchika Nandha| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Kavita Sekhri| President, Tyagi Pharmacy Association & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074, Prof. Satyanand Tyagi
Keywords
Related Articles
- EP ID EP1363
- DOI -
- Views 492
- Downloads 30
A REVIEW ON BILAYER TABLETS
Over the past 30 years stated that the expense and complications involved in marketing new drug entities have increased, with concomitant recognition of therapeutic advantages of controlled drug delivery, greater attenti...
Comparative evaluation of antihypertensive effects of Ramipril vs. Losartan in patients with uncomplicated stage-1 hypertension
Hypertension is responsible for high morbidity and mortality in cardiovascular diseases. As Ramipril and Losartan are important ones due to extensive use, fewer side effects, low cost & availability in market, study was...
Formulation & evaluation of Ofloxacin sustained release matrix tablet
The present study aimed to formulate and evaluate sustained release matrix tablets of Ofloxacin to achieve sustained drug release. Sustained release matrix tablets of Ofloxacin were prepared by wet granulation method usi...
INDUSTRIAL PROCESS VALIDATION: A REVIEW
Validation is defined in the supplementary information section of the Federal Register as “a QA function that helps ensure drug product quality by providing documented evidence that the manufacturing process consistentl...
PHOSPHOLIPASE A2 IN AIRWAY DISEASES: TARGET FOR DRUG DISCOVERY
Importance of the Field: Inflammatory airway diseases are on the rise world over. There is need for orally active, safe and efficacious antiinflammatory agent. Existing therapeutic options are plagued by poor efficacy an...